Browsing by Author "Ferreira, E"
Now showing 1 - 10 of 15
Results Per Page
Sort Options
- Biomarkers and Genetic Modulators of Cerebral Vasculopathy in Sub-Saharan Ancestry Children With Sickle Cell AnemiaPublication . Silva, M; Vargas, S; Coelho, A; Ferreira, E; Mendonça, J; Vieira, L; Maia, R; Dias, A; Ferreira, T; Morais, A; Soares, IM; Lavinha, J; Silva, R; Kjöllerström, P; Faustino, PWe investigated biomarkers and genetic modulators of the cerebral vasculopathy (CV) subphenotype in pediatric sickle cell anemia (SCA) patients of sub-Saharan African ancestry. We found that one VCAM1 promoter haplotype (haplotype 7) and VCAM1 single nucleotide variant rs1409419_T were associated with stroke events, stroke risk, as measured by time-averaged mean of maximum velocity in the middle cerebral artery, and with high serum levels of the hemolysis biomarker lactate dehydrogenase. Furthermore, VCAM-1 ligand coding gene ITGA4 variants rs113276800_A and rs3770138_T showed a positive association with stroke events. An additional positive relationship between a genetic variant and stroke risk was observed for ENPP1 rs1044498_A. Conversely, NOS3 variants were negatively associated with silent cerebral infarct events (VNTR 4b_allele and haplotype V) and CV globally (haplotype VII). The -alpha3.7kb-thal deletion did not show association with CV. However, it was associated with higher red blood cell and neutrophil counts, and lower mean corpuscular volume, mean corpuscular hemoglobin and red cell distribution width. Our results underline the importance of genetic modulators of the CV sub-phenotype and their potential as SCA therapeutic targets. We also propose that a biomarker panel comprising biochemical, hematological, imaging and genetic data would be instrumental for CV prediction, and prevention.
- Cirurgia Reconstrutiva das Grandes Veias Intratorácicas,a Propósito de Quatro Casos ClínicosPublication . Abreu, R; Valentim, H; Martelo, F; Rodrigues, H; Bravio, I; Bastos Gonçalves, F; Ferreira, E; Albuquerque e Castro, J; Fragata, J; Mota Capitão, L; Castro, JA resseção e reconstrução dos grandes troncos venosos do tórax está indicada no tratamento dos sintomas de hipertensão venosa causados pelo Síndrome da Veia Cava Superior e para permitir a ressecção de tumores do mediastino que invadem a Veia Cava Superior (VCS) e os Troncos Venosos Braquiocefálicos (TVB), esquerdo e direito. Apresentamos quatro casos clínicos ilustrativos, operados entre 2010 e 2013. Todos eles sofriam de um tumor do mediastino com envolvimento dos grandes troncos venosos, cujo propósito foi a ressecção completa do tumor. Pretendemos avaliar os resultados em termos de melhoria da sintomatologia, complicações decorrentes dos procedimentos, permeabilidade das pontagens a curto e médio prazo e taxas de mortalidade. Utilizamos próteses de ePTFE aneladas para a realização das seguintes reconstruções vasculares: • pontagem em Y da veia subclávia esquerda e veia jugular interna esquerda para o TVB esquerdo; • duas pontagens do início do TVB esquerdo para o apêndice auricular direito; • pontagem do TVB esquerdo para o apêndice auricular direito e uma pontagem do TVB direito para a VCS. Todos os doentes tiveram alta hospitalar e todas as pontagens se encontravam permeáveis à data da alta e aos 30 dias. Ocorreram dois casos de trombose tardia, contudo os doentes mantiveram-se assintomáticos. A nossa série mostra a exequibilidade destas cirurgias, tecnicamente complexas, que são um excelente exemplo dos benefícios da colaboração multidisciplinar entre cirurgiões vasculares e torácicos.
- Consulta de Úlcera de Perna do Hospital de Santa MartaPublication . Garcia, AC; Vasconcelos, L; Valentim, H; Gonçalves, F; Castro, JM; Ferreira, E; Albuquerque e Castro, J; Mota Capitão, LLeg ulcers constitute a highly prevalent pathology in society, and are particularly common in the Angiology and Vascular Surgery outpatient clinic. The prevalence of these patients in this Department result from the fact that 70% of them display superficial and/or deep venous insufficiency of the lower limbs. To address this problem and optimize the therapeutic approaches available to the Chronic Leg Ulcer (CLU) patients, the Department of Angiology and Vascular Surgery has created, in March 2005, an appointment specific to CLU patients. An evaluation protocol was developed, including ulcer characterization, standardization of the conservative treatment, followed by surgical intervention, whenever required. The results obtained were evaluated 18 months after the onset of this protocol. Analysis of the results revealed that the majority of the patients responded positively to the new therapeutic approach, with closure of the ulcer in 43% of the patients and a significant improvement detected for an additional 30%. Furthermore, it was observed that a detailed evaluation of these patients should be regarded as a whole, followed by a standardized and targeted approach, resulting in a particularly successful approach on the treatment of this pathology.
- Estenose Intra-Stent na Artéria Femoral Superficial: Soluções Actuais Para um Problema CrescentePublication . Rodrigues, H; Bastos Gonçalves, F; Alves, G; Amaral, C; Rodrigues, G; Abreu, R; Quintas, A; Oliveira, N; Ferreira, E; Albuquerque e Castro, J; Mota Capitão, LOs últimos anos de tratamento da doença arterial obstrutiva periférica na artéria femoral superficial observaram uma mudança de paradigma, da cirurgia clássica para a endovascular, o que se traduziu na utilização progressiva de stents metálicos para a manutenção da permeabilidade a longo prazo. Apesar dos avanços tecnológicos, a restenose intra-stent é uma das principais limitações do tratamento endovascular, com um tratamento complexo e não consensual, traduzindo a escassez de resultados obtidos ou a sua manutenção no tempo. Os autores procuraram recolher os dados mais recentes sobre este tipo de patologia e as principais opções disponíveis para o seu tratamento.
- Genetic Modulators of Fetal Hemoglobin Expression and Ischemic Stroke Occurrence in African Descendant Children With Sickle Cell AnemiaPublication . Nicolau, M; Vargas, S; Silva, M; Coelho, A; Ferreira, E; Mendonça, J; Vieira, L; Kjöllerström, P; Maia, R; Silva, R; Dias, A; Ferreira, T; Morais, A; Soares, IM; Lavinha, J; Faustino, PSickle cell anemia (SCA) is an autosomal recessive monogenic disease with significant clinical variability. Cerebrovascular disease, particularly ischemic stroke, is one of the most severe complications of SCA in children. This study aimed to investigate the influence of genetic variants on the levels of fetal hemoglobin (Hb F) and biochemical parameters related with chronic hemolysis, as well as on ischemic stroke risk, in ninety-one unrelated SCA patients, children of sub-Saharan progenitors. Our results show that a higher Hb F level has an inverse relationship with the occurrence of stroke, since the group of patients who suffered stroke presents a significantly lower mean Hb F level (5.34 ± 4.57% versus 9.36 ± 6.48%; p = 0.024). Furthermore, the co-inheritance of alpha-thalassemia improves the chronic hemolytic pattern, evidenced by a decreased reticulocyte count (8.61 ± 3.58% versus 12.85 ± 4.71%; p < 0.001). In addition, our findings have confirmed the importance of HBG2 and BCL11A loci in the regulation of Hb F expression in sub-Saharan African SCA patients, as rs7482144_A, rs11886868_C, and rs4671393_A alleles are significantly associated with a considerable increase in Hb F levels (p = 0.019, p = 0.026, and p = 0.028, respectively). Concerning KLF1, twelve different variants were identified, two of them novel. Seventy-three patients (80.2%) presented at least one variant in this gene. However, no correlation was observed between the presence of these variants and Hb F level, severity of hemolysis, or stroke occurrence, which is consistent with their in silico-predicted minor functional consequences. Thus, we conclude that the prevalence of functional KLF1 variants in a sub-Saharan African background does not seem to be relevant to SCA clinical modulation.
- Giant Aneurysm of the Abdominal AortaPublication . Rodrigues, H; Bastos Gonçalves, F; Ferreira, E
- One Year of Lamivudine Therapy for Portuguese Patients with Chronic Hepatitis BPublication . Areias, J; Calinas, F; Porto, A; Carvalho, A; Freitas, D; Macedo, G; Noronha, R; Cotter, J; Meliço-Silvestre, A; Peixe, R; Pratas, J; Barrote, D; Teixeira, R; Augusto, F; Carrilho, I; Campante, F; Velosa, J; Carvalho, L; Duarte, MA; Guerreiro, H; Pires, C; Silva, A; Cotrim, I; Guedes, F; Tomé, L; Marcelino, M; Gonçalves, C; Ferreira, E; Matos, L; Peixe, P; Esteves, J; Valente, T; Simões, C; Marinho, C; Jasmins, L; Vieira, MJ; Marinho, R; Matos, P; Estevens, J; Carrasquinho, J; Salcedo, G; Parada, P; Teixeira, COBJECTIVE: To assess the efficacy of lamivudine treatment on hepatitis B e antigen (HBeAg) and/or hepatitis B surface antigen (HBsAg) seroconversion, on other virological and serological markers of response including hepatitis B virus (HBV) DNA and serum aminotransferases, and the safety of lamivudine treatment in hepatitis B patients. PATIENTS: This phase III open-label study evaluated the virological and biochemical response to lamivudine in 70 Portuguese patients with HBeAg positive chronic hepatitis B. Patients were treated with lamivudine 100mg once daily for 12 months. METHODS: Antiviral activity was assessed by measuring alanine aminotransferase (ALT)/aspartate aminotransferase (AST) levels at all protocol visits, and hepatitis B serology and HBV DNA were performed at baseline and at month 12 visits. Evaluation of safety and tolerance was based on clinical adverse events and laboratory analyses. RESULTS: The primary endpoint was virological response at month 12, defined as loss of detectable HBeAg from serum with a reduction of HBV DNA to undetectable levels, and this was observed in 19/69 (27.5%) of patients. Almost half of the patients were HBV DNA negative by this time. Mean ALT values decreased steadily during treatment and by 12 months 61% of patients had values within the normal range. HBeAg seroconversion (HBeAg negative, HBeAb positive) was achieved in 27.9% of patients by 12 months, although all patients remained HBsAg positive. CONCLUSION: Lamivudine was well tolerated and the incidence of adverse events was similar to those reported in previous studies. Lamivudine treatment resulted in virological and biochemical improvements in HBeAg positive chronic hepatitis B patients, with HBeAg seroconversion in one-third of patients.
- Procedimentos Endovasculares AórticosPublication . Alves, G; Vasconcelos, L; Gonçalves, F; Rodrigues, H; Valentim, H; Silva Castro, J; Ferreira, E; Albuquerque e Castro, J; Mota Capitão, LOs autores apresentam uma análise retrospectiva de todos os procedimentos endovasculares aórticos realizados no Serviço, até Novembro de 2009. A série inclui 302 doentes, dos quais 246 correspondem ao tratamento electivo de aneurismas da aorta abdominal, 33 ao tratamento de aneurismas da aorta abdominal em contexto de urgência e 23 a procedimentos endovasculares da aorta torácica. O objectivo da análise visa descrever as características epidemiológicas, incluindo patologia associada, assim como mortalidade major e mortalidade aos 30 dias de pós-operatório.
- Radiologia do Grande TraumatizadoPublication . Cebola, N; Duarte, A; Duarte, F; Ferreira, E; Ribeiro, H; Simões, S; Sousa, D
- Reparação Híbrida do Arco Aórtico: Experiência Inicial do Hospital de Santa MartaPublication . Rodrigues, H; Castro, JM; Valentim, H; Laranjeira, A; Ferreira, E; Albuquerque e Castro, J; Fragata, J; Mota Capitão, LObjectives: To retrospectively review the hybrid treatment of the aortic arch with supra-aortic debranching and endo- vascular stent-graft repair in a single institution. Methods: From 2007 to 2010, all patients submitted to aortic debranching procedures were entered into a prospective database analysis. For the present study, only patients with sealing zones 0 and 1, according to the Ishimaru classification, were included. Procedure-related morbimortality was analysed for the open and endovascular procedures. Results: During the study period, we electively performed 6 total aortic debranching and 4 partial aortic debranching procedures in 10 patients. According to the etiology the indications were: 6 aortic arch aneurysms, 2 post-dissection aneu- rysms, 1 false aneurysm and 1 type I endoleak following TEVAR. The proximal sealing zone was Ishimaru zone 0 in six patients and zone 1 in four patients. The TEVAR procedure was delayed in all patients with a completion success of 80% (1 patient died from ruptured aortic aneurysm; 1 patient denied the second procedure and was lost to follow-up). The 30d mortality rate was 10% (patient mentioned above). The main morbidity was: 1 axillar venous thrombosis, 1 case of subclinical myocardial infarction, 1 case of terminal renal insufficiency and 1 case of prolonged ventilation. No permanent cerebral or peripheral neurologic deficit was noted. Conclusions: The hybrid repair of the aortic arch is a feasible and reproducible procedure, and our results are similar to the previously published series. Medium and long-term results are necessary to confirm whether the technique can be regarded as a safe alternative to open surgery in high-risk patients.